The soft‐hard tissue interface of the human periodontium is responsible for periodontal
homeostasis and is essential for normal oral activities. This soft‐hard tissue interface is …

Bone loss or osteoporosis, is a slow-progressing disease that results from dysregulation of
pro-inflammatory cytokines. The FDA has approved number of drugs for bone loss …

How cancer cells and their anchorage-dependent normal counterparts respond to the
adhesion ligand density and stiffness of the same extracellular matrix (ECM) is still not very …

Osteoporosis (OP) is a systemic metabolic skeletal disease which can lead to reduction in
bone mass and increased risk of bone fracture due to the microstructural degradation …

Abstract Background/Aims: Current drug therapies for osteoarthritis (OA) are not practical
because of the cytotoxicity and severe side-effects associated with most of them. Artemisinin …

Osteoarthritis (OA) is a complex degenerative disease in which joint homeostasis is
disrupted, leading to synovial inflammation, cartilage degradation, subchondral bone …

Background Major depressive disorder is a worldwide neuropsychiatric disorder associated
with various symptoms, but current antidepressants used in clinical practice have various …

Abstract Background/Aims: Mechanical loading plays an important role in the regulation of
bone mass. However, bone cells are not always under physiological stress. In some cases …

Calcium phosphate ceramics (CaPs) appear to be suitable alternatives for bone grafts
because of their similarity to bone. Tricalcium phosphate (TCP), hydroxyapatite (HA) and …

Background/Aims: With the aging population increases, senile osteoporosis has become a
global public health problem. Previous evidence has shown that miR-124 has important …